Achieve Life Sciences (ACHV) EBT Growth (1y) (2011 - 2018)
Achieve Life Sciences (ACHV) EBT Growth (1y) (2011 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Achieve Life Sciences |
93.71 Mn |
63.22 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2018 |
2.75% |
| Sep 30, 2018 |
65.53% |
| Jun 30, 2018 |
-1,579.52% |
| Mar 31, 2018 |
-818.54% |
| Dec 31, 2017 |
-510.11% |
| Sep 30, 2017 |
-2,220.99% |
| Dec 31, 2016 |
50.36% |
| Dec 31, 2012 |
-92.61% |
| Sep 30, 2012 |
232.44% |
| Jun 30, 2012 |
-35.45% |
| Mar 31, 2012 |
-125.29% |
| Dec 31, 2011 |
-606.32% |
| Sep 30, 2011 |
35.16% |
| Jun 30, 2011 |
329.44% |
